Filters
Clonality
Type
Reactivity
Gene Name
Isotype
Host
Application
Clone
32 results for " SOCS" - showing 1-32
Standard Curve (Sample)
suppressor of cytokine signaling 3, ELISA Kit (Cat# AAA15464)
Full Name
Human suppressors of cytokine signaling 3, SOCS-3 ELISA Kit
Gene Names
SOCS3; CIS3; SSI3; ATOD4; Cish3; SSI-3; SOCS-3
Reactivity
Human
Pricing
WB (Western Blot)
(ASB10 monoclonal antibody. Western Blot analysis of ASB10 expression in NIH/3T3.)
ASB10, Monoclonal Antibody (Cat# AAA24436)
Full Name
ASB10 (Ankyrin Repeat and SOCS Box Protein 10, ASB-10) APC
Gene Names
ASB10; GLC1F
Reactivity
Human, Mouse, Rat
Applications
EIA, WB
Purity
Purified by Protein A Affinity Chromatography.
Pricing
WB (Western Blot)
(ASB10 monoclonal antibody. Western Blot analysis of ASB10 expression in NIH/3T3.)
ASB10, Monoclonal Antibody (Cat# AAA24731)
Full Name
ASB10 (Ankyrin Repeat and SOCS Box Protein 10, ASB-10) (Biotin)
Gene Names
ASB10; GLC1F
Reactivity
Human, Mouse, Rat
Applications
EIA, WB
Purity
Purified by Protein A Affinity Chromatography.
Pricing
Standard Curve (Sample)
Suppressor of cytokine signaling 1, ELISA Kit (Cat# AAA17385)
Full Name
Mouse Suppressor of cytokine signaling 1 ELISA Kit
Gene Names
SOCS1; JAB; CIS1; SSI1; TIP3; CISH1; SSI-1; SOCS-1
Reactivity
Mouse
Pricing
Standard Curve (Sample)
Suppressors Of Cytokine Signaling 3, ELISA Kit (Cat# AAA16290)
Full Name
Mouse Suppressors Of Cytokine Signaling 3 ELISA Kit
Gene Names
SOCS3; CIS3; SSI3; ATOD4; Cish3; SSI-3; SOCS-3
Reactivity
Mouse
Pricing
Standard Curve (Sample)
Cytokine inducible SH2 containing protein (CISH), ELISA Kit (Cat# AAA27346)
Full Name
Human Cytokine inducible SH2 containing protein (CISH) ELISA Kit
Gene Names
CISH; CIS; G18; SOCS; CIS-1; BACTS2
Reactivity
Human
Pricing
WB (Western Blot)
(ASB10 monoclonal antibody. Western Blot analysis of ASB10 expression in NIH/3T3.)
ASB10, Monoclonal Antibody (Cat# AAA25617)
Full Name
ASB10 (Ankyrin Repeat and SOCS Box Protein 10, ASB-10) (PE)
Reactivity
Human, Mouse, Rat
Applications
EIA, WB
Purity
Purified by Protein A Affinity Chromatography.
Pricing
Standard Curve (Sample)
suppressors of cytokine signaling 1 (SOCS-1), ELISA Kit (Cat# AAA15795)
Full Name
Mouse suppressors of cytokine signaling 1, SOCS-1 ELISA Kit
Gene Names
Socs1; JAB; Cish1; Cish7; SSI-1; SOCS-1
Reactivity
Mouse
Pricing
WB (Western Blot)
(ASB10 monoclonal antibody. Western Blot analysis of ASB10 expression in NIH/3T3.)
ASB10, Monoclonal Antibody (Cat# AAA24043)
Full Name
ASB10 (Ankyrin Repeat and SOCS Box Protein 10, ASB-10)
Gene Names
ASB10; GLC1F
Reactivity
Human, Mouse, Rat
Applications
EL/EIA, WB
Purity
Affinity Purified
Purified by Protein A affinity chromatography.
Purified by Protein A affinity chromatography.
Pricing
WB (Western Blot)
(ASB10 monoclonal antibody. Western Blot analysis of ASB10 expression in NIH/3T3.)
ASB10, Monoclonal Antibody (Cat# AAA25028)
Full Name
ASB10 (Ankyrin Repeat and SOCS Box Protein 10, ASB-10) (FITC)
Gene Names
ASB10; GLC1F
Reactivity
Human, Mouse, Rat
Applications
EIA, WB
Purity
Purified by Protein A Affinity Chromatography.
Pricing
WB (Western Blot)
(ASB9 monoclonal antibody, Western Blot analysis of ASB9 expression in HepG2.)
ASB9, Monoclonal Antibody (Cat# AAA25029)
Full Name
ASB9 (Ankyrin Repeat and SOCS Box Protein 9, ASB-9, DKFZp564L0862, FLJ20636, MGC4954) (FITC)
Reactivity
Human
Applications
EIA, IHC, IP, WB
Purity
Purified by Protein A Affinity Chromatography.
Pricing
Standard Curve (Sample)
Suppressors Of Cytokine Signaling 3 (SOCS3), RTU ELISA Kit (Cat# AAA23982)
Full Name
Human Suppressors Of Cytokine Signaling 3 (SOCS3) ELISA Kit
Gene Names
SOCS3; CIS3; SSI3; ATOD4; Cish3; SSI-3; SOCS-3
Reactivity
Human
Pricing
WB (Western Blot)
(ASB9 monoclonal antibody, Western Blot analysis of ASB9 expression in HepG2.)
ASB9, Monoclonal Antibody (Cat# AAA25618)
Full Name
ASB9 (Ankyrin Repeat and SOCS Box Protein 9, ASB-9, DKFZp564L0862, FLJ20636, MGC4954) (PE)
Reactivity
Human
Applications
EIA, IHC, IP, WB
Purity
Purified by Protein A Affinity Chromatography.
Pricing
WB (Western Blot)
(ASB9 monoclonal antibody, Western Blot analysis of ASB9 expression in HepG2.)
ASB9, Monoclonal Antibody (Cat# AAA24142)
Full Name
ASB9 (Ankyrin Repeat and SOCS Box Protein 9, ASB-9, DKFZp564L0862, FLJ20636, MGC4954) (AP)
Reactivity
Human
Applications
EIA, IHC, IP, WB
Purity
Purified by Protein A Affinity Chromatography.
Pricing
IHC (Immunohistochemistry)
(Immunohistochemistry of paraffin-embedded human gastric cancer using AAA26949 at dilution 1:100)
SOCS4, Polyclonal Antibody (Cat# AAA26949)
Full Name
SOCS4 Antibody
Gene Names
SOCS4; SOCS7
Reactivity
Human, Mouse
Applications
EIA, WB, IHC
Purity
Antigen Affinity Purified
Pricing
WB (Western Blot)
(ASB10 monoclonal antibody. Western Blot analysis of ASB10 expression in NIH/3T3.)
ASB10, Monoclonal Antibody (Cat# AAA24141)
Full Name
ASB10 (Ankyrin Repeat and SOCS Box Protein 10, ASB-10) (AP)
Gene Names
ASB10; GLC1F
Reactivity
Human, Mouse, Rat
Applications
EIA, WB
Purity
Purified by Protein A Affinity Chromatography.
Pricing
WB (Western Blot)
(ASB10 monoclonal antibody. Western Blot analysis of ASB10 expression in NIH/3T3.)
ASB10, Monoclonal Antibody (Cat# AAA25324)
Full Name
ASB10 (Ankyrin Repeat and SOCS Box Protein 10, ASB-10) (HRP)
Gene Names
ASB10; GLC1F
Reactivity
Human, Mouse, Rat
Applications
EIA, WB
Purity
Purified by Protein A Affinity Chromatography.
Pricing
SDS-PAGE
Suppressor of cytokine signaling 1, Recombinant Protein (Cat# AAA18689)
Full Name
Recombinant Human Suppressor of cytokine signaling 1
Gene Names
SOCS1; JAB; CIS1; SSI1; TIP3; CISH1; SSI-1; SOCS-1
Purity
Greater or equal to 85% purity as determined by SDS-PAGE.
Pricing
WB (Western Blot)
(ASB9 monoclonal antibody, Western Blot analysis of ASB9 expression in HepG2.)
ASB9, Monoclonal Antibody (Cat# AAA24437)
Full Name
ASB9 (Ankyrin Repeat and SOCS Box Protein 9, ASB-9, DKFZp564L0862, FLJ20636, MGC4954) APC
Reactivity
Human
Applications
EIA, IHC, IP, WB
Purity
Purified by Protein A Affinity Chromatography.
Pricing
WB (Western Blot)
(ASB9 monoclonal antibody, Western Blot analysis of ASB9 expression in HepG2.)
ASB9, Monoclonal Antibody (Cat# AAA24732)
Full Name
ASB9 (Ankyrin Repeat and SOCS Box Protein 9, ASB-9, DKFZp564L0862, FLJ20636, MGC4954) (Biotin)
Reactivity
Human
Applications
EIA, IHC, IP, WB
Purity
Purified by Protein A Affinity Chromatography.
Pricing
WB (Western Blot)
(ASB9 monoclonal antibody, Western Blot analysis of ASB9 expression in HepG2.)
ASB9, Monoclonal Antibody (Cat# AAA14792)
Full Name
ASB9 (Ankyrin Repeat and SOCS Box Protein 9, ASB-9, DKFZp564L0862, FLJ20636, MGC4954)
Reactivity
Human
Applications
EL/EIA, WB, IP, IHC
Purity
Affinity Purified
Purified by Protein A affinity chromatography.
Purified by Protein A affinity chromatography.
Pricing
WB (Western Blot)
(ASB9 monoclonal antibody, Western Blot analysis of ASB9 expression in HepG2.)
ASB9, Monoclonal Antibody (Cat# AAA25325)
Full Name
ASB9 (Ankyrin Repeat and SOCS Box Protein 9, ASB-9, DKFZp564L0862, FLJ20636, MGC4954) (HRP)
Reactivity
Human
Applications
EIA, IHC, IP, WB
Purity
Purified by Protein A Affinity Chromatography.
Pricing
FCM (Flow Cytometry)
(SOCS1 Antibody (N-term) flow cytometric analysis of WiDr cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.)
SOCS1, Polyclonal Antibody (Cat# AAA28752)
Full Name
SOCS1 Antibody (N-term)
Gene Names
SOCS1; JAB; CIS1; SSI1; TIP3; CISH1; SSI-1; SOCS-1
Reactivity
Mouse, rat
Applications
WB, EIA, IHC, IF, FC
Purity
Purified Rabbit Polyclonal Antibody (Pab)
Pricing
Application Data
(Published customer image: Leukocyte infiltration in COX-2-M/-M and COX-2+/+ mice. MPO enzymatic activity (panel A) was statistically similar in COX-2-M/-M and COX-2+/+ livers at 6 h and 24 h post-IRI. Ly-6G+ neutrophil (panel B) and granulocyte (panel C) infiltration were also comparable in COX-2-M/-M and COX-2+/+ livers after IRI. Mac-1+ (panel D) and CD68 (panel E) infiltrating macrophages were significantly reduced in COX-2-M/-M livers at 24 h post-reperfusion, but were statistically indistinguishable in COX-2-M/-M and COX-2+/+ livers at 6 h after IRI. No statistical differences in MMP-9 expression (panel F) could be demonstrated in livers of COX-2-M/-M and COX-2+/+ mice post-IRI. Representative immunostaining (panel G) of infiltrating Ly-6G+ (a,b,e,f) and Mac-1+ (c,d,g,h) leukocytes in livers of COX-2+/+ (a,c,e,g) and COX-2-M/-M (b,d,f,h) mice at 6 h (a to d) and 24 h (e to h) post IRI; (n = 5 -6/group; * indicates p)
CD68, Monoclonal Antibody (Cat# AAA12104)
Full Name
RAT ANTI MOUSE CD68:Biotin
Gene Names
Cd68; Lamp4; gp110; Scard1
Applications
FC/FACS
Pricing
Application Data
(Published customer image: Leukocyte infiltration in COX-2-M/-M and COX-2+/+ mice. MPO enzymatic activity (panel A) was statistically similar in COX-2-M/-M and COX-2+/+ livers at 6 h and 24 h post-IRI. Ly-6G+ neutrophil (panel B) and granulocyte (panel C) infiltration were also comparable in COX-2-M/-M and COX-2+/+ livers after IRI. Mac-1+ (panel D) and CD68 (panel E) infiltrating macrophages were significantly reduced in COX-2-M/-M livers at 24 h post-reperfusion, but were statistically indistinguishable in COX-2-M/-M and COX-2+/+ livers at 6 h after IRI. No statistical differences in MMP-9 expression (panel F) could be demonstrated in livers of COX-2-M/-M and COX-2+/+ mice post-IRI. Representative immunostaining (panel G) of infiltrating Ly-6G+ (a,b,e,f) and Mac-1+ (c,d,g,h) leukocytes in livers of COX-2+/+ (a,c,e,g) and COX-2-M/-M (b,d,f,h) mice at 6 h (a to d) and 24 h (e to h) post IRI; (n = 5 -6/group; * indicates p)
CD68, Monoclonal Antibody (Cat# AAA12108)
Full Name
RAT ANTI MOUSE CD68:RPE
Gene Names
Cd68; Lamp4; gp110; Scard1
Applications
FC/FACS
Pricing
Application Data
(Published customer image: Leukocyte infiltration in COX-2-M/-M and COX-2+/+ mice. MPO enzymatic activity (panel A) was statistically similar in COX-2-M/-M and COX-2+/+ livers at 6 h and 24 h post-IRI. Ly-6G+ neutrophil (panel B) and granulocyte (panel C) infiltration were also comparable in COX-2-M/-M and COX-2+/+ livers after IRI. Mac-1+ (panel D) and CD68 (panel E) infiltrating macrophages were significantly reduced in COX-2-M/-M livers at 24 h post-reperfusion, but were statistically indistinguishable in COX-2-M/-M and COX-2+/+ livers at 6 h after IRI. No statistical differences in MMP-9 expression (panel F) could be demonstrated in livers of COX-2-M/-M and COX-2+/+ mice post-IRI. Representative immunostaining (panel G) of infiltrating Ly-6G+ (a,b,e,f) and Mac-1+ (c,d,g,h) leukocytes in livers of COX-2+/+ (a,c,e,g) and COX-2-M/-M (b,d,f,h) mice at 6 h (a to d) and 24 h (e to h) post IRI; (n = 5 -6/group; * indicates p)
CD68, Monoclonal Antibody (Cat# AAA12105)
Full Name
RAT ANTI MOUSE CD68:FITC
Gene Names
Cd68; Lamp4; gp110; Scard1
Applications
FC/FACS
Pricing
Application Data
(Published customer image: Leukocyte infiltration in COX-2-M/-M and COX-2+/+ mice. MPO enzymatic activity (panel A) was statistically similar in COX-2-M/-M and COX-2+/+ livers at 6 h and 24 h post-IRI. Ly-6G+ neutrophil (panel B) and granulocyte (panel C) infiltration were also comparable in COX-2-M/-M and COX-2+/+ livers after IRI. Mac-1+ (panel D) and CD68 (panel E) infiltrating macrophages were significantly reduced in COX-2-M/-M livers at 24 h post-reperfusion, but were statistically indistinguishable in COX-2-M/-M and COX-2+/+ livers at 6 h after IRI. No statistical differences in MMP-9 expression (panel F) could be demonstrated in livers of COX-2-M/-M and COX-2+/+ mice post-IRI. Representative immunostaining (panel G) of infiltrating Ly-6G+ (a,b,e,f) and Mac-1+ (c,d,g,h) leukocytes in livers of COX-2+/+ (a,c,e,g) and COX-2-M/-M (b,d,f,h) mice at 6 h (a to d) and 24 h (e to h) post IRI; (n = 5 -6/group; * indicates p)
CD68, Monoclonal Antibody (Cat# AAA12109)
Full Name
RAT ANTI MOUSE CD68:RPE
Gene Names
Cd68; Lamp4; gp110; Scard1
Applications
FC/FACS
Pricing
Application Data
(Published customer image: Leukocyte infiltration in COX-2-M/-M and COX-2+/+ mice. MPO enzymatic activity (panel A) was statistically similar in COX-2-M/-M and COX-2+/+ livers at 6 h and 24 h post-IRI. Ly-6G+ neutrophil (panel B) and granulocyte (panel C) infiltration were also comparable in COX-2-M/-M and COX-2+/+ livers after IRI. Mac-1+ (panel D) and CD68 (panel E) infiltrating macrophages were significantly reduced in COX-2-M/-M livers at 24 h post-reperfusion, but were statistically indistinguishable in COX-2-M/-M and COX-2+/+ livers at 6 h after IRI. No statistical differences in MMP-9 expression (panel F) could be demonstrated in livers of COX-2-M/-M and COX-2+/+ mice post-IRI. Representative immunostaining (panel G) of infiltrating Ly-6G+ (a,b,e,f) and Mac-1+ (c,d,g,h) leukocytes in livers of COX-2+/+ (a,c,e,g) and COX-2-M/-M (b,d,f,h) mice at 6 h (a to d) and 24 h (e to h) post IRI; (n = 5 -6/group; * indicates p)
CD68, Monoclonal Antibody (Cat# AAA12102)
Full Name
RAT ANTI MOUSE CD68
Gene Names
Cd68; Lamp4; gp110; Scard1
Applications
FC/FACS, IF, IP, WB
Pricing
Application Data
(Published customer image: Leukocyte infiltration in COX-2-M/-M and COX-2+/+ mice. MPO enzymatic activity (panel A) was statistically similar in COX-2-M/-M and COX-2+/+ livers at 6 h and 24 h post-IRI. Ly-6G+ neutrophil (panel B) and granulocyte (panel C) infiltration were also comparable in COX-2-M/-M and COX-2+/+ livers after IRI. Mac-1+ (panel D) and CD68 (panel E) infiltrating macrophages were significantly reduced in COX-2-M/-M livers at 24 h post-reperfusion, but were statistically indistinguishable in COX-2-M/-M and COX-2+/+ livers at 6 h after IRI. No statistical differences in MMP-9 expression (panel F) could be demonstrated in livers of COX-2-M/-M and COX-2+/+ mice post-IRI. Representative immunostaining (panel G) of infiltrating Ly-6G+ (a,b,e,f) and Mac-1+ (c,d,g,h) leukocytes in livers of COX-2+/+ (a,c,e,g) and COX-2-M/-M (b,d,f,h) mice at 6 h (a to d) and 24 h (e to h) post IRI; (n = 5 -6/group; * indicates p)
CD68, Monoclonal Antibody (Cat# AAA12106)
Full Name
RAT ANTI MOUSE CD68:FITC
Gene Names
Cd68; Lamp4; gp110; Scard1
Applications
FC/FACS
Pricing
Application Data
(Published customer image: Leukocyte infiltration in COX-2-M/-M and COX-2+/+ mice. MPO enzymatic activity (panel A) was statistically similar in COX-2-M/-M and COX-2+/+ livers at 6 h and 24 h post-IRI. Ly-6G+ neutrophil (panel B) and granulocyte (panel C) infiltration were also comparable in COX-2-M/-M and COX-2+/+ livers after IRI. Mac-1+ (panel D) and CD68 (panel E) infiltrating macrophages were significantly reduced in COX-2-M/-M livers at 24 h post-reperfusion, but were statistically indistinguishable in COX-2-M/-M and COX-2+/+ livers at 6 h after IRI. No statistical differences in MMP-9 expression (panel F) could be demonstrated in livers of COX-2-M/-M and COX-2+/+ mice post-IRI. Representative immunostaining (panel G) of infiltrating Ly-6G+ (a,b,e,f) and Mac-1+ (c,d,g,h) leukocytes in livers of COX-2+/+ (a,c,e,g) and COX-2-M/-M (b,d,f,h) mice at 6 h (a to d) and 24 h (e to h) post IRI; (n = 5 -6/group; * indicates p)
CD68, Monoclonal Antibody (Cat# AAA12103)
Full Name
RAT ANTI MOUSE CD68:Biotin
Gene Names
Cd68; Lamp4; gp110; Scard1
Applications
FC/FACS
Pricing
Application Data
(Published customer image: Leukocyte infiltration in COX-2-M/-M and COX-2+/+ mice. MPO enzymatic activity (panel A) was statistically similar in COX-2-M/-M and COX-2+/+ livers at 6 h and 24 h post-IRI. Ly-6G+ neutrophil (panel B) and granulocyte (panel C) infiltration were also comparable in COX-2-M/-M and COX-2+/+ livers after IRI. Mac-1+ (panel D) and CD68 (panel E) infiltrating macrophages were significantly reduced in COX-2-M/-M livers at 24 h post-reperfusion, but were statistically indistinguishable in COX-2-M/-M and COX-2+/+ livers at 6 h after IRI. No statistical differences in MMP-9 expression (panel F) could be demonstrated in livers of COX-2-M/-M and COX-2+/+ mice post-IRI. Representative immunostaining (panel G) of infiltrating Ly-6G+ (a,b,e,f) and Mac-1+ (c,d,g,h) leukocytes in livers of COX-2+/+ (a,c,e,g) and COX-2-M/-M (b,d,f,h) mice at 6 h (a to d) and 24 h (e to h) post IRI; (n = 5 -6/group; * indicates p)
CD68, Monoclonal Antibody (Cat# AAA12107)
Full Name
RAT ANTI MOUSE CD68
Gene Names
Cd68; Lamp4; gp110; Scard1
Applications
FC/FACS, IF, IP, WB
Purity
Purified
Purified IgG - liquid
Purified IgG - liquid
Pricing
Application Data
(Published customer image: Leukocyte infiltration in COX-2-M/-M and COX-2+/+ mice. MPO enzymatic activity (panel A) was statistically similar in COX-2-M/-M and COX-2+/+ livers at 6 h and 24 h post-IRI. Ly-6G+ neutrophil (panel B) and granulocyte (panel C) infiltration were also comparable in COX-2-M/-M and COX-2+/+ livers after IRI. Mac-1+ (panel D) and CD68 (panel E) infiltrating macrophages were significantly reduced in COX-2-M/-M livers at 24 h post-reperfusion, but were statistically indistinguishable in COX-2-M/-M and COX-2+/+ livers at 6 h after IRI. No statistical differences in MMP-9 expression (panel F) could be demonstrated in livers of COX-2-M/-M and COX-2+/+ mice post-IRI. Representative immunostaining (panel G) of infiltrating Ly-6G+ (a,b,e,f) and Mac-1+ (c,d,g,h) leukocytes in livers of COX-2+/+ (a,c,e,g) and COX-2-M/-M (b,d,f,h) mice at 6 h (a to d) and 24 h (e to h) post IRI; (n = 5 -6/group; * indicates p)
CD68, Monoclonal Antibody (Cat# AAA12110)
Full Name
RAT ANTI MOUSE CD68
Gene Names
Cd68; Lamp4; gp110; Scard1
Applications
FC, IA, IF, IP, WB
Pricing